entertainment -WSS

entertainment

author：entertainment 2025-10-02 18:34:23 Page View：72343

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 'Essentially witchcraft:' A former naturopath takes on the field
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

comprehensive

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

'Essentially witchcraft:' A former naturopath takes on the field

ErosDervishiforSTATBrittHermesonceconsideredherselfadoctor.Now,she’sanapostate.Hermesspentthreeyears

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

CRISPR technology availability, affordability needs to be expanded

Fromleft,STAT'sJasonMast;JuliaVitarello,founder&CEOofMila’sMiracleFoundation;andFyodorUrnov,agen

entertainment

explore

comprehensive

CRISPR technology availability, affordability needs to be expanded